Lizhou Jia

1.4k total citations
45 papers, 968 citations indexed

About

Lizhou Jia is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lizhou Jia has authored 45 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Immunology. Recurrent topics in Lizhou Jia's work include RNA modifications and cancer (10 papers), Immune Cell Function and Interaction (6 papers) and Cancer-related molecular mechanisms research (5 papers). Lizhou Jia is often cited by papers focused on RNA modifications and cancer (10 papers), Immune Cell Function and Interaction (6 papers) and Cancer-related molecular mechanisms research (5 papers). Lizhou Jia collaborates with scholars based in China and United States. Lizhou Jia's co-authors include Wei Zhao, Qi Tang, Lingli Zhang, Zhenqing Feng, Lidao Bao, Yan Li, Sha Na, Jin Zhu, Ruiya Li and Tengqi Wang and has published in prestigious journals such as PLoS ONE, Gut and Scientific Reports.

In The Last Decade

Lizhou Jia

44 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lizhou Jia China	19	468	433	265	224	123	45	968
Yuan Mao China	20	497 1.1×	445 1.0×	152 0.6×	266 1.2×	123 1.0×	58	946
Yuhki Yokoyama Japan	18	1.1k 2.4×	561 1.3×	259 1.0×	196 0.9×	176 1.4×	46	1.6k
Zhangyan Guo China	13	441 0.9×	312 0.7×	317 1.2×	269 1.2×	119 1.0×	18	917
Dylan C. Dean United States	14	555 1.2×	285 0.7×	347 1.3×	185 0.8×	307 2.5×	24	963
Mei‐Kuang Chen United States	12	527 1.1×	912 2.1×	131 0.5×	348 1.6×	191 1.6×	24	1.2k
Denarda Dangaj Laniti Switzerland	15	367 0.8×	703 1.6×	186 0.7×	544 2.4×	78 0.6×	31	1.1k
Chenfei Zhou China	22	786 1.7×	581 1.3×	512 1.9×	329 1.5×	188 1.5×	68	1.5k
Eleni Maniati United Kingdom	19	580 1.2×	750 1.7×	272 1.0×	708 3.2×	155 1.3×	40	1.6k
Qing Hao Miow Singapore	9	529 1.1×	462 1.1×	325 1.2×	75 0.3×	165 1.3×	14	987
Wen-Hsuan Yu Taiwan	6	801 1.7×	1.0k 2.4×	446 1.7×	283 1.3×	191 1.6×	8	1.5k

Countries citing papers authored by Lizhou Jia

Since Specialization

Citations

This map shows the geographic impact of Lizhou Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhou Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhou Jia more than expected).

Fields of papers citing papers by Lizhou Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizhou Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhou Jia. The network helps show where Lizhou Jia may publish in the future.

Co-authorship network of co-authors of Lizhou Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Lizhou Jia. A scholar is included among the top collaborators of Lizhou Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizhou Jia. Lizhou Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yuexin, Lizhou Jia, Yang Liu, Ning Zhang, & Yanmei Li. (2025). Research progress on ferroptosis in drug resistance and therapy of gastric cancer. Journal of Cancer Research and Clinical Oncology. 152(1). 1–1.

Chen, Wei‐Yi, Lingli Zhang, Man Gao, et al.. (2025). Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer. Frontiers in Immunology. 15. 1519034–1519034. 5 indexed citations

Yang, Lixin, Tengqi Wang, Dexin Zhang, et al.. (2023). Black Phosphorus Nanosheets Assist Nanoerythrosomes for Efficient mRNA Vaccine Delivery and Immune Activation. Advanced Healthcare Materials. 12(26). e2300935–e2300935. 19 indexed citations

Zhang, Ning, et al.. (2022). JAG1 is associated with the prognosis and metastasis in breast cancer. Scientific Reports. 12(1). 21986–21986. 6 indexed citations

Jia, Lizhou, Tengqi Wang, Youcai Zhao, et al.. (2021). Single-cell profiling of infiltrating B cells and tertiary lymphoid structures in the TME of gastric adenocarcinomas. OncoImmunology. 10(1). 1969767–1969767. 34 indexed citations

Guo, Jiaojiao, Jingjing Wang, Lizhou Jia, et al.. (2021). Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma. Frontiers in Oncology. 11. 546586–546586. 53 indexed citations

Jia, Lizhou, Tingting Yang, Xiaochen Huang, et al.. (2020). Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Medical Science Monitor. 26. e919566–e919566. 11 indexed citations

Wang, Xiaohui, Jiaojiao Guo, Meng Dai, et al.. (2020). PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis. Journal of Cancer. 11(12). 3467–3475. 14 indexed citations

Wang, Tengqi, et al.. (2019). POM121 overexpression is related to a poor prognosis in colorectal cancer. Expert Review of Molecular Diagnostics. 20(3). 345–353. 14 indexed citations

10.

Ma, Yilan, Mingjiong Zhang, Xiaochen Huang, et al.. (2019). High-Affinity Human Anti-c-Met IgG Conjugated to Oxaliplatin as Targeted Chemotherapy for Hepatocellular Carcinoma. Frontiers in Oncology. 9. 717–717. 19 indexed citations

11.

Li, Lijuan, et al.. (2019). POM121 is identified as a novel prognostic marker of oral squamous cell carcinoma. Journal of Cancer. 10(19). 4473–4480. 16 indexed citations

12.

Tang, Qi, Lizhou Jia, Li Jing, et al.. (2018). High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Pathology - Research and Practice. 214(10). 1606–1612. 27 indexed citations

13.

Jia, Lizhou, Tingting Yang, Xuan Gu, et al.. (2018). Translation elongation factor eEF1Bα is identified as a novel prognostic marker of gastric cancer. International Journal of Biological Macromolecules. 126. 345–351. 7 indexed citations

14.

Xu, Yunzhao, Chenyi Wang, Yuquan Zhang, Lizhou Jia, & Jianfei Huang. (2015). Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer. Scientific Reports. 5(1). 12104–12104. 43 indexed citations

15.

Jia, Lizhou, et al.. (2015). The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer. Clinical & Translational Oncology. 18(3). 233–239. 12 indexed citations

16.

Xu, Li, Lizhou Jia, Hongling Yi, et al.. (2014). Factors Influencing Styrene- Acrylic Emulsion Application Performance. Cailiao yanjiu xuebao. 28(1). 75–80. 1 indexed citations

17.

Li, Ruiya, Lingli Zhang, Lizhou Jia, et al.. (2014). Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation. PLoS ONE. 9(6). e100893–e100893. 131 indexed citations

18.

Xu, Xia, Yan Wang, Fang Wang, et al.. (2013). Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer. Journal of Ovarian Research. 6(1). 31–31. 18 indexed citations

19.

Jia, Lizhou, Shiwu Zhang, Yanfen Ye, et al.. (2012). Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells. Cancer Letters. 326(2). 176–182. 42 indexed citations

20.

Liu, Li‐Li, Jun Liang, Huihong Zhai, et al.. (2009). Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein. Gut. 59(3). 292–299. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact